Merit Financial Group LLC Has $11.26 Million Stock Position in Synopsys, Inc. $SNPS

Merit Financial Group LLC boosted its holdings in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 15.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 25,247 shares of the semiconductor company’s stock after acquiring an additional 3,392 shares during the quarter. Merit Financial Group LLC’s holdings in Synopsys were worth $11,262,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in SNPS. Sankala Group LLC bought a new stake in Synopsys during the 4th quarter worth approximately $25,000. Elevation Wealth Partners LLC grew its holdings in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after buying an additional 27 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in Synopsys in the 4th quarter valued at $28,000. IMG Wealth Management Inc. purchased a new stake in Synopsys in the 1st quarter valued at $30,000. Finally, Atlas Capital Advisors Inc. bought a new position in Synopsys during the 4th quarter valued at $32,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analyst Upgrades and Downgrades

SNPS has been the subject of several recent analyst reports. KeyCorp reiterated an “overweight” rating on shares of Synopsys in a research note on Thursday, May 28th. BNP Paribas Exane boosted their price target on shares of Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a report on Thursday, May 28th. Zacks Research raised shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Bank of America increased their price objective on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Finally, Morgan Stanley upped their target price on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $565.06.

View Our Latest Stock Analysis on SNPS

Insider Activity at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

Synopsys Trading Down 0.1%

NASDAQ:SNPS opened at $411.75 on Friday. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $626.24. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The firm’s 50 day moving average is $426.49 and its 200 day moving average is $443.50. The stock has a market capitalization of $78.84 billion, a PE ratio of 95.31, a price-to-earnings-growth ratio of 2.42 and a beta of 1.23.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business’s revenue for the quarter was up 41.9% on a year-over-year basis. During the same period last year, the business posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Sell-side analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.